Stocksigma LogoStocksigma Logo

Shelter Pharma Reports Zero Deviation in Preferential Issue Fund Utilization

Shelter Pharma confirmed nil deviation or variation in utilizing proceeds from its convertible warrant preferential issue for the half-year ended 30th

Shelter Pharma Reports Zero Deviation in Preferential Issue Fund Utilization

Shelter Pharma Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 11:23 pm

Shelter Pharma Reports Zero Deviation in Preferential Issue Fund Utilization Shelter Pharma confirmed nil deviation or variation in utilizing proceeds from its convertible warrant preferential issue for the half-year ended 30th Sep'26. Total funds raised amounted to Rs. 2,602.50 lakh, comprising Rs. 930.35 lakh from 25% warrant subscription (88.08 lakh warrants at Rs. 42.25/share) and Rs. 1,672.15 lakh from converting 52.77 lakh warrants. The company fully deployed Rs. 2,531.20 lakh toward working capital requirements and Rs. 71.30 lakh for general corporate purposes, strictly adhering to objects approved in its 23rd Jul'25 EGM.

Original exchange filing (PDF)

More announcements from Shelter Pharma Ltd

All Shelter Pharma Ltd announcements